Loading...
Loading...
Among the 8 tracked institutional investors we monitor, PLRX (PLIANT THERAPEUTICS INC) is held with a combined value of $13.13M across 10,512,426 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $4.11M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$13.13M
Total Shares Held
10,512,426
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $4.11M | 0.00% | +20.5% |
| 2 | VANGUARD GROUP INC | $3.44M | 0.00% | New |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $2.33M | 0.00% | +77.2% |
| 4 | MILLENNIUM MANAGEMENT LLC | $1.49M | 0.00% | +188.8% |
| 5 | BlackRock, Inc. | $1.38M | 0.00% | +2.2% |
| 6 | STATE STREET CORP | $319.31K | 0.00% | - |
| 7 | Point72 Asset Management, L.P. | $59.29K | 0.00% | +1.1% |
| 8 | FMR LLC | $660 | 0.00% | -72.9% |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of PLRX with a position worth $4.11M, representing 0.00% of their portfolio. In total, 8 institutional investors hold PLRX with a combined value of $13.13M.
In the most recent quarter, 1 fund opened a new position in PLRX. Additionally, 5 increased their holdings and 1 reduced their positions.
Institutional investors hold $13.13M worth of PLRX stock across 8 positions. The largest institutional holder is CITADEL ADVISORS LLC with $4.11M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PLRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PLRX positions.